Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Paracetamol
  • 1.4.3 Ibuprofen
  • 1.4.4 Aspirin
  • 1.4.5 Naproxen
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
• 2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
  • 2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
  • 3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
  • 3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
  • 3.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
• 3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
• 3.4 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
• 3.5 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
• 4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
• 5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
• 6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
• 7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

8 China

• 8.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
• 8.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 8.4 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
• 9.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 9.4 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

11 India

• 11.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
• 11.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 11.4 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
• 12.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
• 12.4 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis
  • 13.1.1 Novartis Company Details
  • 13.1.2 Novartis Business Overview
  • 13.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
  • 13.1.5 Novartis Recent Development
• 13.2 Pfizer
  • 13.2.1 Pfizer Company Details
  • 13.2.2 Pfizer Business Overview
  • 13.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.2.5 Pfizer Recent Development
• 13.3 Boehringer Ingelheim
  • 13.3.1 Boehringer Ingelheim Company Details
  • 13.3.2 Boehringer Ingelheim Business Overview
  • 13.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim Recent Development
• 13.4 Teva Pharmaceutical
  • 13.4.1 Teva Pharmaceutical Company Details
  • 13.4.2 Teva Pharmaceutical Business Overview
  • 13.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.4.5 Teva Pharmaceutical Recent Development
• 13.5 Hospira
  • 13.5.1 Hospira Company Details
  • 13.5.2 Hospira Business Overview
  • 13.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.5.5 Hospira Recent Development
• 13.6 Lonza Group
  • 13.6.1 Lonza Group Company Details
  • 13.6.2 Lonza Group Business Overview
  • 13.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.6.5 Lonza Group Recent Development
• 13.7 Mylan
  • 13.7.1 Mylan Company Details
  • 13.7.2 Mylan Business Overview
  • 13.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.7.5 Mylan Recent Development
• 13.8 Aurobindo Pharma
  • 13.8.1 Aurobindo Pharma Company Details
  • 13.8.2 Aurobindo Pharma Business Overview
  • 13.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.8.5 Aurobindo Pharma Recent Development
• 13.9 Dr. Reddy's Laboratories
  • 13.9.1 Dr. Reddy's Laboratories Company Details
  • 13.9.2 Dr. Reddy's Laboratories Business Overview
  • 13.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.9.5 Dr. Reddy's Laboratories Recent Development
• 13.10 Actavis
  • 13.10.1 Actavis Company Details
  • 13.10.2 Actavis Business Overview
  • 13.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 13.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 13.10.5 Actavis Recent Development
• 13.11 Wuxi Apptec
  • 10.11.1 Wuxi Apptec Company Details
  • 10.11.2 Wuxi Apptec Business Overview
  • 10.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 10.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 10.11.5 Wuxi Apptec Recent Development
• 13.12 Zhejiang NHU
  • 10.12.1 Zhejiang NHU Company Details
  • 10.12.2 Zhejiang NHU Business Overview
  • 10.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
  • 10.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
  • 10.12.5 Zhejiang NHU Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer